News

Unique wing patterns make identification of bee species possible

Published : Thursday, October 30, 2014

The advent of DNA barcoding techniques speeded up the identification and characterization of new species and yielded many new insights. However, these techniques are not always applicable. For example, in most fossils DNA is not present and the Jurrasic Park techniques to dinosaur blood from a mosquito trapped in amber, still remains wishful thinking.
>Read more in Dutch

Strategic Investment by SkylineDx in Cancer Vaccine Company DCPrime

Published : Tuesday, October 28, 2014

SkylineDx, an innovative company in the field of genetic testing for blood cancers, announced a strategic investment of an undisclosed sum in the Dutch cancer vaccine company DCPrime. The financing is designed to provide DCPrime with funding for the development of its technology platform and to take advantage of the synergies between the cancer companies.

Galapagos and Calchan collaborate on osteoarthritis research, £2.4 million grant awarded by Innovate UK

Published : Monday, October 27, 2014

Galapagos NV, a clinical stage biotech company focused on developing novel mode of action medicines, and Calchan Limited, a UK company focused on the development of novel medicines based on calcium ion channel modulators, announced that they have entered into a research collaboration in the area of osteoarthritis pain. 

LUMC Science Day

Published : Monday, October 27, 2014

Leiden Bio Science Park foundation was present at the LUMC Science Day at October 26th. The very popular open day consists of a large fair with LUMC departments, all kind of tests and lectures.
Leiden Bio Science Park foundation organised 4 lectures that accompanied the viewing of the Red carpet (Rode Loper) films about the chain of drug development at Leiden Bio Science Park.

Leiden Bio Science Park foundation visited Japan

Published : Saturday, October 25, 2014

Beginning of October Thijs de Kleer, director and Ellen Smit, senior account manager, both of the Leiden Bio Science Park foundation visited Japan. During this trip, they visited life sciences companies including AnGes, Daiichi Sankyo and Maruho. A small seminar was organized by the Osaka Pharmaceutical Manufacturers Association where Leiden Bio Science Park was presented to life science companies in Osaka.

Councillors and MPs visited Leiden Bio Science Park

Published : Tuesday, October 21, 2014

Members of the last March newly elected city council were invited for introductory programs by various stakeholders in the city, amongst whom the Leiden Bio Science Park foundation and the entrepreneurial society OV BSP.

Galapagos discloses novel target and presents favorable Phase 1 data for GLPG1205 at UEG Week

Published : Monday, October 20, 2014

Galapagos discloses GPR84 as a promising novel target for treating inflammatory bowel disease during an oral presentation at United European Gastroenterology Week in Vienna on 21 October.  Furthermore, Galapagos presents a poster disclosing favorable Phase 1 results with GLPG1205, the first clinical compound ever developed against target GPR84. 

CHDR proudly announces the establishment of a new research area: Translational Biomarkers

Published : Friday, October 17, 2014

Drugs that will be developed in the future will increasingly affect pathophysiological pathways that have been largely unexplored. Such drug prototypes cannot immediately be introduced in large clinical trials, but require rational exploration in tailored early phase clinical studies, with biomarkers that are fit-to-purpose.

Treeway and Leiden Academic Center for Drug Research collaborate

Published : Wednesday, October 15, 2014

Treeway and LACDR at the University of Leiden join forces and form a collaboration focused on the optimization of clinical trial designs and data-analysis for ALS (Amyotrophic Lateral Sclerosis) through the use of population disease progression models. Furthermore both parties aim to obtain a better understanding of the disease by developing ALS physiology-based disease models and to test the effect of interventions in the different identified pathways.

Partners Technolab awarded

Published : Wednesday, October 15, 2014

For Technolab Leiden’s approach, collaboration is essential. This remains to be the basis for an inspiring exchange that is beneficial to each. Partners that have been of particular importance for Technolab have been honored by awarding them with a trophy.
> Read more in Dutch

Pluriomics raises €4M in a Series A round to accelerate growth of the company

Published : Wednesday, October 15, 2014

Pluriomics announced that it has raised €4 million in a Series A round led by Vesalius Biocapital (VBC) with additional financing from InnovationQuarter (IQ) and Société régionale d'Investissement de Wallonie (SRIW).
The funds will be used to further develop Pluriomics’ innovative stem cell derived cardiomyocytes and assays and to commercialize these technologies. Pluriomics will strengthen its R&D and commercial team in Leiden while setting-up a production facility in Gosselies, thereby leveraging the expertise available in South Holland and Wallonia.

Condi Food nominated for Herman Wijffels Innovation Award: vote now!

Published : Monday, October 13, 2014

Condi Food is one of the three nominees for the Herman Wijffels Innovation Award in the field of Food en Agriculture. Of 595 entries, Condi is one of the final 9 nominees for three fields of interest. Condi Food has a chance to win a prize with your help!

Pharming and Swedish Orphan Biovitrum amend and extend Ruconest distribution agreement

Published : Monday, October 13, 2014

Biotech company Pharming Group NV and Swedish Orphan Biovitrum AB (publ) or “Sobi”, announced the amendment and extension of the Ruconest® distribution agreement between Pharming and Sobi. Effective immediately, Pharming will focus on direct commercialization in Austria, Germany and Netherlands, and Sobi will extend its Ruconest® sales territory with the addition of Azerbaijan, Belarus, Georgia, Kazakhstan, Russia, Serbia and Ukraine.

Groundbreaking ceremony Biotech Training Facility (BTF)

Published : Friday, October 10, 2014

On October 10th he groundbreaking ceremony for the Biotech Training Facility (BTF) took place in Leiden at the Bio Science Park.This facility is aimed at the training of personnel for the biotechnology and the pharma industry. The BTF will be a real GMP production plant, where all unit operations that are important for the industry will be present. People can get the training they need there, in a standard series of courses or in tailor made training sessions.The first students can enter the BTF in Q4 2015.

Prosensa begins NDA submission to the FDA for exon-skipping drug drisapersen to treat Duchenne muscular dystrophy

Published : Friday, October 10, 2014

Prosensa Holding N.V. the biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, announced that it has commenced the submission process for a New Drug Application (NDA) regulatory filing to the United States Food and Drug Administration (FDA) for its lead exon-skipping drug candidate, drisapersen, for treating Duchenne muscular dystrophy (DMD). The drug received "Fast Track status" from the FDA, making it eligible for a rolling review of an NDA and was also granted "Breakthrough Therapy Designation" in June 2013.

Innovative MedTech-idea?

Published : Friday, October 10, 2014

Do you have a medical and technological innovative MedTech-idea? Please send it in, win 5000 euro and build your first prototype!
> Read more in Dutch

Mimetas raises 5.2 million dollar for organ-on-a-chip

Published : Wednesday, October 8, 2014

Dutch biotech MIMETAS B.V. announced that it has raised 5.2 million dollar to fund its expansion as a global leader in organ-on-a-chip technology. Venture capital investors Zeeuws Investerings Fonds (ZIF) and Participatiemaatschapij Oost Nederland (PPM Oost) have joined forces with national and regional partners to fund development and sales of MIMETAS’ unique 3D disease- and tissue modelling technologies.

High ranking for Leiden University in the THE World Rankings

Published : Monday, October 6, 2014

Leiden University, in 64th position, is the highest-ranking Dutch University in the Times Higher Education Rankings (THE). Leiden has risen by three places since last year. THE ranks universities on teaching, research and innovation.

HRM-network rebooted!

Published : Sunday, October 5, 2014

On October 2nd, our team organized a meeting for HR professionals working at Leiden Bio Science Park. As the attendance to this meeting was close to 40 participants, it was clear that there still is an interest in this previously existing platform.

LSP raises EUR 80 mln to invest in medical innovations

Published : Tuesday, September 30, 2014

LSP (Life Sciences Partners) announced that it has raised EUR 80 mln (USD 100 mln) for its new fund LSP 5. This fund will continue LSP’s proven and successful strategy of investing in emerging private companies with innovative medicines and medical technologies. Investors stated that they selected LSP because of its impact on healthcare and its consistently strong financial performance.

Volgende »

Newsletter

The Leiden Bio Science Park newsletter is a free bimonthly email newsletter in English. The newsletter offers general life science news, news from the companies and institutions, a company profile, events and jobs.
click here to subscribe

RSS

RSS